The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Eisai; Lilly; Novartis; Takeda
Speakers' Bureau - Lilly
Research Funding - Lilly; Novartis; Pfizer
Travel, Accommodations, Expenses - Bayer; Lilly; Novartis; Pfizer; PharmaMar
SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma.
 
Dejka M. Araujo
No Relationships to Disclose
 
Mihaela Druta
Honoraria - Daiichi Sankyo; Eisai; Lilly
Consulting or Advisory Role - Immune Design; Lilly
Speakers' Bureau - Eisai; Lilly
Travel, Accommodations, Expenses - Daiichi Sankyo; Eisai; Lilly
 
Mark Agulnik
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Lilly; Regeneron
Speakers' Bureau - Bayer; Bristol-Myers Squibb
 
Sandra P. D'Angelo
Consulting or Advisory Role - Adaptimmune; Amgen; EMD Serono; GlaxoSmithKline; Immune design; Incyte; Merck; Nektar
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); EMD Serono (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst)
Travel, Accommodations, Expenses - Adaptimmune; EMD Serono; Nektar
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Pharmamar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Sandra J Strauss
No Relationships to Disclose
 
Claudia Valverde
No Relationships to Disclose
 
Albiruni Ryan Abdul Razak
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Adaptimmune; Boehringer Ingelheim; Lilly; Merck
Research Funding - Abbvie; Adaptimmune; Amgen; Blueprint Medicines; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; CASI Pharmaceuticals; Deciphera; GlaxoSmithKline; Iterion Therapeutics; Karyopharm Therapeutics; Lilly; MedImmune; Merck; Novartis; Pfizer; Roche/Genentech
 
Erin Van Winkle
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune
 
Trupti Trivedi
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune
 
Swethajit Biswas
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Dennis Williams
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune
 
Elliot Norry
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune